It is therefore not unconceivable that exacerbated activation of MEF2 and NFATc by the MALEP BRIL in OI type V could lead to a combination of pathological consequences affecting early mesenchymal progenitors and/or differentiated osteoblast activity. This evidence concerns the gene NFATC1 and osteogenesis imperfecta type 5.